Clinical Trials
- Liver, Obesity & Weight Management
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
- Ages12 years - 18 years
- GenderBoth
- Liver
test
- Ages18 years and older
- GenderBoth
- Children's Health, Endocrine System, Immune System
Study to investigate adipocyte cell and lipid turnover in obese adolescents
- Ages12 years - 21 years
- GenderBoth
- Liver, Obesity & Weight Management
Effects of Hepatic Ultrasound on Metabolic Homeostasis
- Ages18 years - 60 years
- GenderBoth
- Hepatitis, HIV/AIDS, Immune System, Infectious Disease
Screening In Anticipation of Future Research
- Ages2 years - 17 years
- GenderBoth
- Endocrine System, Genetics
test
- Ages18 years - 60 years
- GenderBoth
- Phase 1 Cancers
test
- Leukemia
Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
- Prostate Cancer
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Ages18 years and older
- GenderMale only
- Hepatitis, Liver
Digoxin In Alcohol Associated Hepatitis
- Ages21 years - 65 years
- GenderBoth